Tiny antibody fragments raised in camels find drug targets in human breast cancer cells
Monday, April 11, 2011 - 23:30
in Health & Medicine
A new discovery promises to help physicians identify patients most likely to benefit from breast cancer drug therapies. If the compound, called "Nanobody," proves effective in clinical trials, it would represent a significant advance for breast cancer drug therapy.